Overview of Burkitt Lymphoma, the Patient Populations Most Impacted
October 25th 2021Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, discusses his SOHO 2021 conference presentation on prognostication and treatment of Burkitt lymphoma in the modern era.
Watch
FDA Approves PD-L1 Test To Evaluate Patients With NSCLC Eligible to Receive Atezolizumab
October 25th 2021Officials with the FDA have approved Roche’s VENTANA PD-L1 (SP263) Assay as a diagnostic test to evaluate patients with non-small cell lung cancer (NSCLC) who are eligible to receive atezolizumab (Tecentriq, Genentech).
Read More
This World Standards Week, USP Sheds Light on Key Shifts in Standards Development
October 25th 2021World Standards Week is October 25 to 29, so Pharmacy Times interviewed Jaap Venema, PhD, EVP and CSO at USP, on some of the key shifts that have occurred in USP’s standards development during the COVID-19 pandemic.
Watch